These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19201067)

  • 1. [Bleeding secondary to vitamin K antagonist treatment: adaptation of the International Normalized Ratio (INR) determination during high hypertriglyceridemia].
    Miot S; Marteau AT; Simard G; Lavigne C
    Rev Med Interne; 2010 Jan; 31(1):60-2. PubMed ID: 19201067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients.
    Karrowni W; Wang TY; Chen AY; Thomas L; Saucedo JF; El Accaoui RN
    Heart; 2015 Feb; 101(4):264-70. PubMed ID: 25336230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
    Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of vitamin K antagonist overcoagulation.
    Marie I; Leprince P; Menard JF; Tharasse C; Levesque H
    QJM; 2012 Jan; 105(1):53-62. PubMed ID: 21880698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to optimal dosing of vitamin K antagonists.
    Witt DM
    Semin Thromb Hemost; 2012 Oct; 38(7):667-72. PubMed ID: 22893509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis to assess the quality of international normalized ratio control and associated outcomes in venous thromboembolism patients.
    Mearns ES; Kohn CG; Song JS; Hawthorne J; Meng J; White CM; Raut MK; Schein JR; Coleman CI
    Thromb Res; 2014 Aug; 134(2):310-9. PubMed ID: 24935672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased levels of procoagulant phospholipids in bleeding patients treated by vitamin K antagonists.
    Mathieu E; Van Dreden P; Aulagnier J; Grusse M; Dreyfus JF; François D; Vasse M
    Thromb Res; 2016 Jan; 137():36-40. PubMed ID: 26632514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mid-term results of self-testing of the international normalized ratio in adults with a mechanical heart valve.
    Azarnoush K; Dorigo E; Pereira B; Dauphin C; Geoffroy E; Dauphin N; D'Ostrevy N; Legault B; Camilleri L
    Thromb Res; 2014 Feb; 133(2):149-53. PubMed ID: 24112749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversing vitamin K antagonists: making the old new again.
    Eichinger S
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):605-611. PubMed ID: 27913535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telemedicine-guided, very low-dose international normalized ratio self-control in patients with mechanical heart valve implants.
    Koertke H; Zittermann A; Wagner O; Secer S; ; Sciangula A; Saggau W; Sack FU; Ennker J; Cremer J; Musumeci F; Gummert JF
    Eur Heart J; 2015 Jun; 36(21):1297-305. PubMed ID: 25205534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term quality of VKA treatment and clinical outcome after extreme overanticoagulation in 14,777 AF and VTE patients.
    Kooistra HA; Veeger NJ; Khorsand N; Kluin-Nelemans HC; Meijer K; Piersma-Wichers M
    Thromb Haemost; 2015 Apr; 113(4):881-90. PubMed ID: 25518854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors for Bleeding in Hospitalized at Risk Patients With an INR of 5 or More Treated With Vitamin K Antagonists.
    Liabeuf S; Scaltieux LM; Masmoudi K; Roussel B; Moragny J; Andrejak M; Gras-Champel V
    Medicine (Baltimore); 2015 Dec; 94(52):e2366. PubMed ID: 26717378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. French clinical practice guidelines on the management of patients on vitamin K antagonists in at-risk situations (overdose, risk of bleeding, and active bleeding).
    Pernod G; Godiér A; Gozalo C; Tremey B; Sié P;
    Thromb Res; 2010 Sep; 126(3):e167-74. PubMed ID: 20630568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The interaction between anticoagulant therapy with vitamin K-antagonists and treatment with antibiotics: a practical recommendation].
    Zelis M; Zweegman S; van der Meer FJ; Kramer MH; Smulders YM
    Ned Tijdschr Geneeskd; 2008 May; 152(18):1042-6. PubMed ID: 18547025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From vitamin K antagonists to liver international normalized ratio: a historical journey and critical perspective.
    Gatt A; Chen D; Pruthi RK; Kamath PS; Leise MD; Ashrani AA; Nichols WL; He R
    Semin Thromb Hemost; 2014 Nov; 40(8):845-51. PubMed ID: 25393635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism.
    Veeger NJ; Piersma-Wichers M; Tijssen JG; Hillege HL; van der Meer J
    Br J Haematol; 2005 Feb; 128(4):513-9. PubMed ID: 15686461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent predictors of poor vitamin K antagonist control in venous thromboembolism patients. Data from the EINSTEIN-DVT and PE studies.
    Kooistra HA; Gebel M; Sahin K; Lensing AW; Meijer K
    Thromb Haemost; 2015 Nov; 114(6):1136-43. PubMed ID: 26224199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.
    Riess HB; Meier-Hellmann A; Motsch J; Elias M; Kursten FW; Dempfle CE
    Thromb Res; 2007; 121(1):9-16. PubMed ID: 17407788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate.
    Majeed A; Meijer K; Larrazabal R; Arnberg F; Luijckx GJ; Roberts RS; Schulman S
    Thromb Haemost; 2014 Feb; 111(2):233-9. PubMed ID: 24154891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major bleeding with vitamin K antagonist anticoagulants in pulmonary hypertension.
    Henkens IR; Hazenoot T; Boonstra A; Huisman MV; Vonk-Noordegraaf A
    Eur Respir J; 2013 Apr; 41(4):872-8. PubMed ID: 22936704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.